Who owns Cue Biopharma Inc?
- Ticker: CUE
- CUSIP Number: 22978p106
Tip: Access positions for across all investors
Analyze quarterly positions in Cue Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cue Biopharma stock
Who bought or sold Cue Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.3M | $4.3M | 7% | Mar 2024 |
|
| BlackRock | 2.2M | $4.2M | 5% | Mar 2024 |
|
| Bleichroeder | 1.8M | $4.6M | 132% | Dec 2023 |
|
| Geode Capital Management | 839k | $1.6M | 10% | Mar 2024 |
|
| Robertson Stephens Wealth Management | 479k | $904k | 0% | Mar 2024 |
|
| Dimensional Fund Advisors | 431k | $815k | -6% | Mar 2024 |
|
| Northern Trust | 365k | $690k | 11% | Mar 2024 |
|
| Millennium Management | 362k | $684k | 31% | Mar 2024 |
|
| Monaco Asset Management SAM | 335k | $633k | -2% | Mar 2024 |
|
| Sigma Planning | 256k | $484k | 135% | Mar 2024 |
|
| Bank of America Corporation | 244k | $460k | -8% | Mar 2024 |
|
| GSA Capital Partners | 209k | $395k | 1399% | Mar 2024 |
|
| Stifel Financial | 193k | $364k | -1% | Mar 2024 |
|
| Citadel Advisors | 165k | $313k | 122% | Mar 2024 |
|
| Morgan Stanley | 150k | $283k | 20% | Mar 2024 |
|
| Nuveen Asset Management | 146k | $277k | -24% | Mar 2024 |
|
| Squarepoint Ops | 116k | $220k | 166% | Mar 2024 |
|
| Good Life Advisors | 100k | $189k | 0% | Mar 2024 |
|
| UBS Group | 93k | $176k | -6% | Mar 2024 |
|
| Bank of New York Mellon | 92k | $174k | -16% | Mar 2024 |
|
| Charles Schwab Investment Management | 92k | $173k | -13% | Mar 2024 |
|
| HighTower Advisors | 78k | $147k | -1% | Mar 2024 |
|
| Susquehanna International | 67k | $126k | -31% | Mar 2024 |
|
| Annandale Capital | 65k | $172k | 0% | Dec 2023 |
|
| CornerCap Investment Counsel | 58k | $109k | 0% | Mar 2024 |
|
| Goldman Sachs Group | 46k | $86k | -22% | Mar 2024 |
|
| Wedmont Private Capital | 40k | $76k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 33k | $62k | 3% | Mar 2024 |
|
| Baker Avenue Asset Management | 32k | $61k | 0% | Mar 2024 |
|
| Barclays | 31k | $59k | -43% | Mar 2024 |
|
| Wells Fargo & Company | 31k | $58k | 5% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 30k | $56k | 0% | Mar 2024 |
|
| Occudo Quantitative Strategies | 29k | $55k | -13% | Mar 2024 |
|
| Nantahala Capital Management | 27k | $50k | 0% | Mar 2024 |
|
| Navalign | 25k | $47k | 0% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 22k | $42k | 0% | Mar 2024 |
|
| Two Sigma Investments | 20k | $38k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 18k | $34k | 7% | Mar 2024 |
|
| American International | 18k | $47k | 4% | Dec 2023 |
|
| Jpmorgan Chase & Co | 15k | $29k | -31% | Mar 2024 |
|
| Ing Investment Management | 13k | $25k | -8% | Mar 2024 |
|
| SeaCrest Wealth Management | 13k | $25k | -7% | Mar 2024 |
|
| LPL Financial | 13k | $24k | 22% | Mar 2024 |
|
| Acadian Asset Management | 12k | $23k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 12k | $22k | 0% | Mar 2024 |
|
| Toroso Investments | 12k | $22k | 100% | Mar 2024 |
|
| Legacy Capital Group California | 10k | $19k | 0% | Mar 2024 |
|
| Beacon Pointe Advisors | 10k | $26k | 0% | Dec 2023 |
|
| Simplex Trading | 9.5k | $18k | 100% | Mar 2024 |
|
| Citigroup | 6.1k | $12k | 9% | Mar 2024 |
|
| Gleason Group | 6.0k | $11k | 0% | Mar 2024 |
|
| Legal & General Group | 4.2k | $8.0k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 3.6k | $6.8k | -53% | Mar 2024 |
|
| Tower Research Capital | 3.3k | $6.2k | -41% | Mar 2024 |
|
| Newbridge Financial Services Group | 3.0k | $5.7k | 0% | Mar 2024 |
|
| FMR | 2.9k | $5.6k | 65% | Mar 2024 |
|
| Summit Investment Advisors | 2.9k | $5.4k | 0% | Mar 2024 |
|
| Brian McDonald | 2.0k | $3.8k | 100% | Mar 2024 |
|
| Amalgamated Bank | 1.2k | $2.0k | -76% | Mar 2024 |
|
| American Capital Advisory | 1.0k | $3.6k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.0k | $0 | -92% | Mar 2024 |
|
| Beaird Harris Wealth Management | 797.00 | $1.5k | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 500.00 | $945.000000 | 0% | Mar 2024 |
|
| Harbour Investments | 439.00 | $1.2k | 0% | Dec 2023 |
|
| Advisor Group Holdings | 380.00 | $718.010000 | 513% | Mar 2024 |
|
| Sunbelt Securities | 237.00 | $448.001100 | 0% | Mar 2024 |
|
| Armstrong Advisory Group | 120.00 | $317.004000 | 0% | Mar 2024 |
|
| IFP Advisors | 100.00 | $264.000000 | 100% | Dec 2023 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 7.00 | $12.999700 | 100% | Mar 2024 |
|
| CWM | 2.00 | $0 | 100% | Mar 2024 |
|
| Assetmark | 2.00 | $4.000000 | 100% | Mar 2024 |
|
Who sold out of Cue Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2023 | 55k | $144k |
| XTX Topco | Sep 2023 | 53k | $123k |
| Caption Management | Dec 2023 | 25k | $65k |
| AQR Capital Management | Dec 2023 | 22k | $59k |
| American Century Companies | Sep 2023 | 22k | $50k |
| T. Rowe Price Associates | Dec 2023 | 18k | $49k |
| Group One Trading | Sep 2023 | 5.3k | $12k |
| Advisory Services Network | Dec 2023 | 200.00 | $528.000000 |
| Russell Investments | Dec 2023 | 172.00 | $453.994000 |
| Farther Finance Advisors | Dec 2023 | 22.00 | $58.000800 |
| NISA Investment Advisors | Dec 2023 | 20.00 | $53.000000 |